In animal studies, DSIP demonstrated anxiolytic effects, reducing anxiety-like behavior in mice (Shekunova et al., 2002), and lowering plasma corticosterone levels in rats (Kovalzon et al., 1997)
Gastrointestinal Symptoms : Some individuals might experience nausea, vomiting, diarrhea, or an upset stomach
There is also growing interest in partners that can support technology transfers
Strategies to Prevent Rapid Weight Regain Without Continuous Therapy If discontinuing semaglutide is necessary, evidence suggests that gradual dose reductionrather than abrupt cessationmay reduce rebound appetite severity and allow behavioral adaptations to solidify
Package Not Child-Resistant For Institutional Use Only Rx ONLY Distributed by: American Health Packaging Columbus, OH 43217 T0675C050226 R02/26 Package/Label Display Panel 250 mg per 5 mL Cup Lid Rx Only NDC 60687- 942-40 VALPROIC ACID ORAL SOLUTION USP 250 mg/5 mL Delivers 5 mL See package insert for full prescribing information and storage
